Clinical Trials
Duchenne Muscular Dystrophy (Duchenne)
Recruiting
Children with Duchenne aged 4 to 9 years on stable corticosteroids
Becker Muscular Dystrophy (Becker)
Recruiting
Adults with Becker aged 18 to 50 years
Active, Not Recruiting
Individuals with Becker aged 12 to 50 years
Active, Not Recruiting
Adults with Becker aged 18 to 55 years old
Healthy Adults
Recruiting
A Phase 1 trial designed to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of EDG-7500 in healthy adults.
Developing new therapies for people with muscle disorders.
Edgewise is committed to developing new therapies for people living with severe, genetic neuromuscular or cardiac disorders. Novel therapies require years of laboratory research and clinical testing to evaluate safety and efficacy. Volunteers who enroll in clinical trials help Edgewise evaluate the potential benefits and safety profile of these investigational therapies in humans. Additionally, investigational therapies must successfully progress through various phases of clinical research before they can be approved for use in the clinical setting.
Please click the orange buttons to learn more about our active clinical trials and see if you qualify to participate. By taking part in one of our clinical trials, you can help us make a difference for the entire community of people living with severe, genetic neuromuscular or cardiac disorders.